Ticlopidine-induced aplastic anemia: Development of chromosomal abnormalities and response to immunosuppressive therapy [PDF]
Vinod Pullarkat+3 more
openalex +1 more source
Safety and Efficacy of Ticlopidine After Stent Placement [PDF]
Patrick Henry, Fabrice Béverelli
openalex +1 more source
.: Stroke is the second cause of mortality worldwide, and intravenous administration of tissue plasminogen activator (t-PA) within 3 h of symptom onset is the only treatment proven effective for re-establishment of cerebral blood flow following acute ...
Masamitsu Shimazawa, Hideaki Hara
doaj
Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac Events [PDF]
Steven R. Steinhubl+4 more
openalex +1 more source
Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]
Priyadharshini A+4 more
europepmc +1 more source
PLATELET ACTIVITY IN PATIENTS TREATED WITH TICLOPIDINE OR SODIUM OZAGREL
H Wada
openalex +2 more sources
A Randomized Comparison of Cilostazol Versus Ticlopidine Therapy After Elective Coronary Stent Implantaion [PDF]
Jin Ho Song+6 more
openalex +1 more source
Development and Characterization of pFluor50, a Fluorogenic-Based Kinetic Assay System for High-Throughput Inhibition Screening and Characterization of Time-Dependent Inhibition and Inhibition Type for Six Human CYPs. [PDF]
Shriwas P+8 more
europepmc +1 more source